Tuesday, October 04, 2011
Something smells off with this - grant to fund travel to meeting, if you use Roche technologies
Just got this email from Roche announcing a grant program to pay registration and travel fees for the AGBT meeting if you are using Roche-454 sequencing or Roche-Nimblegen arrays as part of your work (see below). Seems like this would have some of the same conflict of interest issues as a pharma company paying someone to give a talk. I note - I participated in a session supported by 454 at a meeting but paid my own way to avoid this type of conflict of interest issue. Anyone have opinions on this? Is this a common pharma method creeping its way more and more into genomics?
Subscribe to:
Post Comments (Atom)
-
I have a new friend in Google Scholar Updates I have written about the Updates system before and if you want more information please see... -
See Isolation and sequence-based characterization of a koala symbiont: Lonepinella koalarum Paper based on PhD thesis work of Katie Dahlha...
-
Just got this press release by email. I am sick of receiving dozens of unsolicited press releases, especially those in topics not related ...
Interesting post - I hadn't considered being sponsored by the makers of a piece of equipment you use to be much of a conflict of interest (although admittedly I am newish to the world of scientific conferences). I can see it being a problem if your abstract is basically "Roche equipment is amazing" but do you think it is also a problem if the abstract is "using roche equipment we found..." ?
ReplyDeleteIf you did receive the grant isn't it normal practice to write this on your poster/say it in your presentation? That would point out any possible conflict of interest to your audience. Or do you think that is not enough?